Leqembi approved for the treatment of Alzheimer's disease in Hong Kong
STOCKHOLM, July 11, 2024 /PRNewswire/ -- BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that the Department of Health in Hong Kong has approved Leqembi® (brand name in Hong Kong: "樂意保®", generic name: …